Glatopa is the first FDA-approved substitutable generic of Copaxone® (glatiramer acetate injection) 20 mg/mL for the treatment of patients with relapsing-forms of multiple sclerosis.1-4
Glatopa is an FDA approved, AP-rated, substitutable generic glatiramer acetate that is therapeutically equivalent to Copaxone® 20 mg/mL1-5:
- Contains the same active ingredient
- Same indication
- Is identical in strength, dosage and route of administration
- Meets the same requirements for safety and efficacy, purity and quality
- Demonstrates no observable differences in physiochemical, biological or immunological properties
*Glatopa 20 mg/mL dose is not interchangeable with glatiramer acetate 40 mg/mL dose.
†Demonstrated equivalence to Copaxone® 20 mg/mL.1,2
Glatopa is therapeutically equivalent to Copaxone® 20 mg/mL, with FREE ongoing, individualized patient support services from Sandoz, a Novartis Division.
Please see full Prescribing Information for Glatopa.